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Abstract
After entry into target cells, retroviruses encounter the host restriction factors such as Fv1 and TRIM5a. While it is clear that
these factors target retrovirus capsid proteins (CA), recognition remains poorly defined in the absence of structural
information. To better understand the binding interaction between TRIM5a and CA, we selected a panel of novel N-tropic
murine leukaemia virus (N-MLV) escape mutants by a serial passage of replication competent N-MLV in rhesus macaque
TRIM5a (rhTRIM5a)-positive cells using a small percentage of unrestricted cells to allow multiple rounds of virus replication.
The newly identified mutations, many of which involve changes in charge, are distributed over the outer ‘top’ surface of N-
MLV CA, including the N-terminal b-hairpin, and map up to 29 A
o apart. Biological characterisation with a number of
restriction factors revealed that only one of the new mutations affects restriction by human TRIM5a, indicating significant
differences in the binding interaction between N-MLV and the two TRIM5as, whereas three of the mutations result in dual
sensitivity to Fv1
n and Fv1
b. Structural studies of two mutants show that no major changes in the overall CA conformation
are associated with escape from restriction. We conclude that interactions involving much, if not all, of the surface of CA are
vital for TRIM5a binding.
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Introduction
Mammalian cells show different susceptibilities to retrovirus
infection. Cells from mice exhibit different susceptibility to murine
leukaemia virus (MLV) dependent on their genetic backgrounds;
cell lines from different primates show defined patterns of lentiviral
replication. In many cases, these variations are due to the presence
of cellular proteins referred as restriction factors. The susceptibility
to MLV infection in mouse cells is determined by a restriction
factor called Fv1; different alleles of Fv1 restricting different strains
of MLV. Fv1
n restricts B-tropic MLV (B-MLV) but not N-tropic
MLV (N-MLV) infections, whereas Fv1
b does the reverse [1,2,3].
In primate cells, lentivirus and N-MLV are restricted by a second
restriction factor, TRIM5a [4,5,6,7,8]. TRIM5 is a member of a
large family of tri-partite motif proteins that contain RING, B-box
and coiled-coil motifs, sometimes referred to collectively as an
RBCC domain [9,10]. The a isoform of TRIM5 (TRIM5a) also
has an additional large B30.2 or PRYSPRY domain at its C-
terminus [11,12], important for recognizing the viral target
[13,14,15,16]. Both Fv1 [17,18] and TRIM5a [5,19] target the
viral capsid protein (CA), blocking retrovirus replication after viral
entry into the target cell. Restriction by TRIM5a, however, is
clearly distinguished from that by Fv1 in that TRIM5a-mediated
restriction normally occurs before or during reverse transcription
[5,20], whereas Fv1-mediated restriction occurs after the comple-
tion of reverse transcription but prior to viral integration [21,22].
One of the most surprising features of TRIM5a restriction is the
ability of TRIM5as from different species to recognize and restrict
multiple unrelated viruses often across different retroviral genera.
For example, TRIM5a from the cotton-top tamarin can recognize
at least one member from each of the lentivirus, gammaretrovirus,
betaretrovirus and spumavirus genera and rhesus monkey (rh)
TRIM5a will restrict both HIV-1 and N-MLV [23,24,25].
Although it is clear that Fv1 and TRIM5a target viral CA, in
the absence of structural information the recognition process
remains poorly defined. However, it appears likely that single-site
binding is weak and that a productive interaction required for
restriction is multivalent and dependent on the spacing of CA
monomers/hexamers in the viral core [26,27,28].
One approach to investigating the problem of restriction
specificity has been through genetic characterisation of naturally
occurring or experimentally induced variants in CA that alter virus
tropism [29]. In this way amino acid residues involved in the
interaction with restriction factors have been identified. In the case
of Fv1-mediated restriction of MLV, it is known that several
surface-exposed amino acids in the region between a-helices 4 and
6 in CA, which include amino acids at positions 82, 92–94, 110,
114 and 117, can change the tropism of MLV [30]. Among these
PLoS Pathogens | www.plospathogens.org 1 March 2011 | Volume 7 | Issue 3 | e1002011positions, the amino acid at position 110 is the main determinant,
since substitution of amino acid at position 110 (Arg for N-tropic
and Glu for B-tropic MLV) can switch the tropism of MLV [31].
Structural studies show that amino acids in positions 110, 114 and
117 are located in a-helix 6, residue 82 is in the loop between a-
helices 4 and 5, and amino acids 92–94 are located in a-helix 5
[32]. Therefore, the region between a-helices 4 and 6 might be
considered a ‘Fv1-binding pocket’ [27]. A number of amino acid
substitution experiments have also suggested that this a4–a6
region may also contribute to TRIM5a-mediated restriction of N-
MLV. These include an R110E mutation that confers resistance of
N-MLV to restriction by human (hu) TRIM5a and an E110R
mutation in B-MLV that results in susceptibility to restriction by
huTRIM5a [19]. Other substitutions in CA at positions 82, 114
and 117 alter the TRIM5a species range able to restrict B- and N-
MLV [8] and domain-swap experiments suggested that the
equivalent region in HIV and other lentiviruses also contains the
host-range determining segments [33,34,35,36].
In this study, replication competent N-MLV was passaged in
rhTRIM5a-positive cells to search for escape mutations in sites
important for restriction and in the context of a natural infection.
We isolated a number of N-MLV escape mutants, including
substitutions at the previously identified positions 82 and 114.
However, of particular interest is a new class of mutations
including G8D, L10W and V116D that were discovered. They
map outside the putative Fv1 binding pocket and display subtle
structural changes. In these instances, escape from restriction by
rhTRIM5a was conferred, but restriction by huTRIM5a was not
affected. These observations have defined new regions of N-MLV
CA that control virus growth in the presence of TRIM5a, revealed
that the restriction factor-CA interface is larger than previously
thought and shown that subtle changes in CA structure can have
profound effects on TRIM5a susceptibility.
Results
In an initial attempt to isolate MLV variants resistant to
TRIM5a-mediated restriction, Mus dunni tail fibroblasts (MDTF),
MDTF expressing YFP and huTRIM5a (MDHu) or rhTRIM5a
(MDRh) were inoculated with different dilutions of replication
competent N-MLV (Stock A) and the infected cells were passed
repeatedly. On each passage, the culture supernatant was
harvested and reverse transcriptase (RT) activity in the filtered
culture supernatant measured (Figure 1). After only three days
high RT levels were measured in restriction factor-negative cells,
even when the target cells were initially infected with low titre
(1:100 diluted virus) (Figure 1A). When restriction factor-negative
cells were infected with the high titre undiluted virus, the RT
activity decreased sharply at 6 days post infection (d.p.i.) but later
recovered, due to virus-mediated cytopathic effects. In cells
expressing huTRIM5a N-MLV replication was restricted com-
pletely, even when undiluted virus was inoculated (Figure 1B). By
contrast, cells expressing rhTRIM5a did not prevent replication of
high titre virus, and, although the time of RT release was delayed,
maximal levels were similar to those seen with MDTF (compare
Figure 1C and Figure 1A). No virus was recovered from MDRh
infected with 1:10 or 1:100 diluted N-MLV (Figure 1C).
Taken together, these data imply (a) huTRIM5a restriction of
N-MLV is more potent than that of rhTRIM5a and (b)
rhTRIM5a restriction can be overcome by high levels of wild-
type N-MLV in a rapid manner, presumably by saturation.
However, under these conditions, an extended period of virus
replication against a background of restriction does not seem to
occur leaving little opportunity for escape mutants to arise. To
maximize the chances of generating and recovering escape
mutants we decided to focus on searching for escape mutants
from rhTRIM5a using low input virus to avoid restriction factor
saturation. To allow continued virus replication under selective
conditions a mixture of MDTF and MDRh was infected.
Generation and selection of N-MLV escape mutants from
rhesus TRIM5a
Low titres of N-MLV were used to infect a mixture of 90%
TRIM5a-positive and 10% TRIM5a-negative cells. Virus spread
was monitored by fluorescence staining using a monoclonal
antibody directed against the viral p12 protein. As shown in
Figure 2A, virus-infected cell populations were clearly distinguish-
able from virus-negative cells both in YFP-negative (TRIM5a-
negative) and -positive (TRIM5a-positive) populations. Following
infection of the first mixed culture, a small fraction of the YFP-
positive cells appeared virus-positive as early as 3 d.p.i.; the virus
spread into about 30% of the YFP-positive cell population within
13 d.p.i. and 60% by 18 d.p.i. (Figure 2B iv-vi). The culture
supernatant was then collected, filtered, diluted tenfold and passed
again in mixed cell culture for a further ten days (2
nd culture). To
select mutant viruses, the filtered and diluted culture supernatant
from the second mixed cell culture was inoculated onto 100%
MDRh cells (the 3
rd and 4
th cultures). In contrast to wild type N-
MLV, which at 1:10 dilution had shown no virus expansion during
the first 18 days of MDRh culture (Figure 1C), the virus from the
second culture took 7 days to grow in 100% MDRh cells in the
third culture (Figure 2B). This was not a result of different levels of
viral input because virus with RT activity of 20 mU was
inoculated in the third culture compared to 514 mU RT activity
in the first inoculum. The virus at the end of the third culture was
stored and referred to as rhesus TRIM5a-escape mutant 1
(REM1).
This procedure was repeated a further three times starting with
N-MLV Stock A yielding REM2-4. In each experiment a similar
time course was observed for isolation of a virus capable of
unrestricted growth in the presence of rhTRIM5a. These results
clearly demonstrate the utility of unrestricted refugia in the
isolation of escape mutants from rhTRIM5a by allowing growth
against a background of restriction.
The primary target for Fv1 and TRIM5a restriction is thought
to be the viral CA protein. It was thus expected that escape
mutations would map to the capsid so the nucleotide sequences of
the capsid region of the viral gag gene was determined by direct
sequencing of viral cDNA amplified from viral RNA in the culture
supernatant. These data revealed that REM1 had acquired a
single nucleotide substitution from T to G at nucleotide 1309
Author Summary
Host restriction factors such as TRIM5a are important for
preventing cross species transmission of a variety of
retroviruses. They act to block viral replication but their
mode of virus recognition is poorly understood. To address
this question we have developed a procedure for isolating
viruses that replicate in the presence of restriction factors.
Analysis of these viruses shows that individual mutations
across the entire surface of the viral capsid molecule can
relieve restriction. Escape from TRIM5a of one species does
not necessarily lead to escape from another. It seems likely
that restriction factor recognition involves extensive weak
contacts between factor and virus. We suggest that this
represents an important design feature in a system that
recognizes multiple pathogens.
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tryptophan substitution at amino acid position 10 in CA. The
same L10W mutation in CA was seen in four independent
experiments (isolates REM1-4) and no other mutations were
detected in the capsid gene. This suggested that a small population
of viruses carrying the L10W mutant may already exist in the virus
stock prepared from the culture supernatant of chronically infected
cells (Stock A) and the mutant was selected in the course of the
virus passage experiments. As a first test of this hypothesis, the
capsid gene of Stock A virus was amplified by RT-PCR and
cloned. No sequence variation was observed in 50 independent
clones (all 50 clones yielded sequences identical to N-MLV derived
from pWN41) indicating that any minority species can only be
present at very low levels.
We next derived a second stock of virus by transfection of 293T
cells with self-ligated pWN41 provirus followed by three cell-free
transfers to MDTF cells (Stock B). Two independent experiments
with the new N-MLV stock following the same protocol used to
isolate REM 1-4resulted inthe isolation of potential escapemutants
REM5, 6. The only change in the capsid genes in these two viruses
Figure 1. Growth of replication competent N-MLV in human and rhesus macaque TRIM5a-expressing MDTF cells. TRIM5a-negative
MDTF cells (A), human TRIM5a-positive MDTF cells (B) and rhesus macaque TRIM5a-positive MDTF cells (C) were inoculated with different dilutions of
replication competent Stock A N-MLV (undiluted, cross; 10-fold diluted, triangle; 100-fold dilution, circle). Infected cells were passed twice a week for
eighteen days monitoring RT activity in the culture supernatant. Similar results were obtained from two independent experiments, one example is
shown.
doi:10.1371/journal.ppat.1002011.g001
Figure 2. Selection of escape mutants from rhesus macaque TRIM5a. Escape mutants were derived by growing N-MLV on cell cultures
containing mixed populations of TRIM5a-expressing and non-expressing MDTF cells. Virus spread was monitored by staining with an antibody
specific to p12; the presence of TRIM5a was indicated by YFP. (A) Representative FACS profiles. (i) uninfected MDTF cells, (ii) MDTF cells 3 days post
infection (d.p.i.) with N-MLV stained with anti-p12 (iii) – (vi) panels showing 90% TRIM5-positive cells at 0 d.p.i. (iii), 3 d.p.i. (iv), 13 d.p.i. (v) and 20 d.p.i.
(vi) with N-MLV. Note that YFP-positive cell population shifted up into the dual-positive fraction. (B) Emergence of escape mutant in the culture. The
percentage of p12 viral antigen positive cells in the culture was plotted against the time, d.p.i. Cells were passaged every 3 days for three weeks
before cell-free virus passage to establish the next culture. The first and second cultures were performed in the mixed cell culture of TRIM5-positive
cells with 10% TRIM5-negative cells, followed by the third and forth cultures with 100% TRIM5-positive cells. In the mixed cell cultures, p12-positive
cell percentages were calculated for the YFP positive cells. Input RT activities: 1
st culture 514 mU; 2
nd culture 1151 mU; 3
rd culture 20 mU; 4
th culture
712 mU.
doi:10.1371/journal.ppat.1002011.g002
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V116D mutation. Four further experiments with freshly prepared
Stock Bs gave rise to REM7-10; three carried single mutations
resulting in L10W, H114N and H114R changes whereas REM10
carried three mutations causing L4S/A95D/S202G alterations.
A third set of experiments used Stock C, which was recovered
directly following transfection of human 293T cells without
passage through murine cells and should therefore have no
mutations associated with reverse transcription (pWN41 encodes
an ecotropic virus which will only infect murine cells), led to the
isolation of REM11-15. Sequencing studies showed that these
viruses carried mutations resulting in the following changes: G8D,
N82D (twice), E92K and H114D.
To confirm the importance of these mutations in escape from
rhTRIM5a they were introduced by Quikchange PCR into the N-
MLV vector, pCIG3N and the resulting viruses tested for growth
with different restriction factors. On the basis of these analyses
(Figure 3 and Supplementary Figure S1), the escape mutants could
be placed into two groups depending on the degree of residual
sensitivity to rhTRIM5a. One group, typified by L10W and
comprising L10W, H114D, H114N, H114R and E92K showed
equivalent titration curves in the presence and absence of rhesus
TRIM5a (though E92K grew poorly compared to wild type N-
MLV). The second group, typified by V116D, contained in
addition G8D and N82D. This group showed slightly reduced
infectivity in the presence of rhTRIM5a. Two of the single amino
acid changes present in the triple mutant, L4S and A95D, gave
rise to viruses that would fall in the second group but together
show complete resistance. The S202G change appeared to have
no effect on restriction, as might be expected for a residue in the
(interior) C terminal domain of CA. Perhaps surprisingly, only one
of the mutations that result in escape from rhTRIM5a, E92K,
affects restriction by huTRIM5a. Furthermore, three of the
mutations that give rise to resistance to rhTRIM5a, G8D, H114D
and V116D confer sensitivity to Fv1
n while maintaining Fv1
b
susceptibility. These data are summarized in Table 1.
Mutant capsids are resistant to rhesus macaque TRIM5a
mediated disassembly
Since mutations at positions 10 and 116 have not previously
been reported to affect interactions with Fv1 or TRIM5a we next
set out to explore the properties of the L10W and V116D
mutations. To examine the interaction between viral cores
carrying the L10W and V116D mutations and rhTRIM5a,w e
tested whether such cores would resist rhTRIM5a mediated
disassembly using the previously described fate-of-capsid assay that
follows the premature capsid disassembly thought to occur in an
infected cell following virus encountering TRIM5a [38]. As
expected, wt N-MLV cores were pelleted in TRIM5a-negative cell
extract (Figure 4, lane 1) and B-MLV capsid cores, but not wt N-
MLV, L10W and V116D mutant capsid cores, were pelleted when
huTRIM5a-expressing cells were infected (Figure 4, lanes 2–5).
This result was consistent with the observations that huTRIM5a
restricted wt N-MLV, L10W and V116D mutant viruses, but not
B-MLV. In contrast, in the presence of rhTRIM5a, B-MLV and
the L10W and V116D N-MLVs were pelleted, but wild type N-
Figure 3. Restriction of N-MLV vectors carrying L10W and V116D. eGFP-encoding vector virus (A, wild type N-MLV; B, B-MLV; C, N-
MLV(L10W); D, N-MLV(V116D)) were titrated on MDTF cells stably expressing restriction factors (TRIM5-negative, open diamond; human TRIM5a, filled
square; rhesus TRIM5a, filled red triangle; Fv1
b, filled circle; Fv1
n, asterisk). Experiments were performed in triplicate; mean values from one
representative experiment from three are plotted.
doi:10.1371/journal.ppat.1002011.g003
TRIM5a-Escape Mutants of MLV
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Therefore, L10W and V116D mutant viruses escape disassembly
of capsid core caused by rhTRIM5a, an observation consistent
with the lack of restriction of these mutant viruses by rhTRIM5a
and emphasizing the species-specific nature of escape by L10W
and V116D mutants from TRIM5a.
Restriction profiles of L10 mutants and V116D by primate
TRIM5as
The selectivity difference of rhesus and human TRIM5as
prompted us to carry out a more detailed survey of the restriction
profiles. Firstly, as only the L10W mutation was isolated through
the in vivo passaging experiments we wondered what the effect of
other residue types at position 10 in N-MLV CA might have on
restriction factor sensitivity. To address this possibility, random
amino acids were introduced at position 10 by PCR mutagenesis.
Using this procedure fourteen of the possible nineteen substitutions
and wt silent codon changes were recovered. The restriction data
for rhTRIM5a are shown in Supplementary Figure S2 and
summarized in Table 2. Out of the entire panel only two
additional mutants, L10H and L10K, giving complete escape were
identified. Two other substitutions (L10P and L10V) resulted in wt
restriction phenotype; another gave non-infectious virus (L10R),
whereas the remainder display intermediate phenotypes with
restriction by TRIM5a at low virus titre but with only moderate
restriction at higher virus titre. The variable phenotypes produced
in this experiment highlight the importance of MLV residue 10
suggesting a direct involvement/interaction of this part of CA with
rhTRIM5a in restriction of N-MLV but do not suggest a direct
correlation between restriction activity and the size or charge of
the amino acid residue at position 10.
Next we tested the ability of a previously described panel of
primate TRIM5as to restrict the L10W, L10K, L10H and V116D
mutant viruses [24]. Wild type N-MLV was restricted by all the
ape and old world monkey TRIM5as tested as well as some of the
new world monkey TRIM5a including from Cotton-top tamarin
and Brown capuchin (Table 3 and Supplementary Figure S3). All
the L10 escape mutants were also restricted by ape TRIM5as,
which was perhaps not unexpected given the observation that
huTRIM5a restricted the L10W mutant virus. However, among
old world monkey TRIM5as, only African green monkey
TRIM5a restricted the L10 mutants and in each case these
mutations also resulted in escape from restriction by the capuchin
factor. On the other hand, the restriction profile of the V116D
mutant virus was rather different. It was not restricted by orang-
utan TRIM5a but was restricted by sooty mangabey and Brown
capuchin TRIM5as. These observations showed that whereas the
viruses with mutations at position 10 showed a similar phenotype
in terms of restriction by TRIM5a, the V116D mutant exhibited a
different restriction profile by primate TRIM5a. These results
imply that capsid recognition by TRIM5as of different species
may involve interactions with different amino acids on CA.
Involvement of B30.2 V1 and V2 regions in N-MLV CA
recognition
These species differences in restriction profiles of the escape
mutants allowed us to use a previously described series of chimeric
human/macaque TRIM5as [16], to ask which of the V1, V2 and
V3 variable regions of the TRIM5a B30.2 domain are important
for CA binding (Figure 5, Supplementary Figure S4). Each chimera
was designed to contain a different combination of the variable
Table 1. Summary of the restriction profiles of the escape
mutants.
Restriction
Virus HuTRIM5 RhTRIM5 Fv1b Fv1n
wtN-MLV ++ ++ ++ 2
B-MLV + 2 ++ +
L4S ++ + ++ 2
G8D ++ + ++ ++
L10W ++ 2 ++ 2
N82D ++ + ++ 2
E92K 2222
A95D ++ + ++ 2
H114D ++ 2 ++ ++
H114N ++ 2 ++ 2
H114R ++ 2 ++ 2
V116D ++ + ++ ++
L4S/A95D ++ 2 ++ 2
For primary restriction data for these mutants, see Supplemental data (Figure
S1). Similar results were obtained from three independent experiments.
++: more than 10-fold reduction of infectivity compare to wild type, +:2 -t o1 0 -
fold reduction of infectivity compare to wild type, -: less than 2-fold reduction
of infectivity compare to wild type.
doi:10.1371/journal.ppat.1002011.t001
Figure 4. Capsid cores from escape mutants are not disassem-
bled by rhesus TRIM5a. The interaction of TRIM5a with incoming
capsid cores was studied in TRIM5a-expressing cells infected with VSV-
G envelope-pseudotyped viruses. After lyzing infected cells in
hypotonic buffer without detergent, cell extract was overlayered above
50% sucrose cushion and centrifuged. The presence of CA protein was
examined in cell extract (upper panel; input), supernatant (middle
panel; soluble) and pelleted (bottom panel; pellet) fractions. Represen-
tative results from one of three independent experiments are shown.
doi:10.1371/journal.ppat.1002011.g004
Table 2. Restriction sensitivity of CA10 mutants.
Amino acid at position 10
Full restriction L, P and V
Partial restriction A, C, D, F, N, Q, S and T
No restriction H, K and W
Less infectivity R
For primary restriction data from these mutants, see Supplemental data (Figure
S2). Similar results were obtained from three independent experiments.
doi:10.1371/journal.ppat.1002011.t002
TRIM5a-Escape Mutants of MLV
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TRIM5a restrictN-MLV and sonot surprisinglyMDTF cellsstably
expressing each of the eight chimeric TRIM5as restricted wild type
N-MLV. The position 10 mutants (L10W, L10K and L10H) show
identical patterns of sensitivity to the chimeric constructs, being
unrestricted by HR4, RH3 and RH4, but restricted by the other
chimericTRIM5a, suggesting that when eitherthe V1or V2region
is derived from huTRIM5a, the mutants are restricted, whereas
when both V1 and V2 regions were derived from rhTRIM5a, the
mutant N-MLV was not restricted. The V116D escape mutant also
displays an identical profile to that of the position 10 mutants,
supporting the idea that both V1 and V2 regions are involved in
TRIM5a-mediated restriction of MLV.
The effect of b1-b2 mutations on HIV-1 susceptibility to
Rhesus TRIM5a
The N-terminal domain of HIV-1 and MLV CAs share very
similar structures [32], including the b-hairpin region. It therefore
seemed possible that this region might affect sensitivity of HIV-1 to
rhesus TRIM5a. To address this question, each amino acid
between position 5 and 12 on HIV-1 capsid, which form the N-
terminal b-hairpin loop, was substituted with a lysine residue. In
addition, the methionine residue at position 10 of HIV-1 capsid
was substituted randomly by mutagenesis PCR. However,
although several of these mutations severely impaired Gag
function, none of the viable HIV-1 mutants examined in this
study, escaped rhTRIM5a (Supplementary Figure S5), implying
that unlike MLV, the N-terminal b-hairpin loop of HIV-1 capsid
does not seem to affect the restriction activity of TRIM5a. Based
on these results, the ways by which rhTRIM5a recognizes viral
capsid seems to be different between HIV and MLV.
Structure of N-MLV CA carrying the L10W mutation
On inspection of the structure of the MLV CA-NtD (Mortuza et
al., 2004) it was apparent that although the side chains of both
residues 10 and 116 were surface exposed on an assembled capsid
structure, neither lay in the a4–a6 region, previously proposed as
the Fv1 binding site (Mortuza et al., 2008). Residue 116 was
located on the second turn of a6 on the face opposite the a4–a6
region while residue 10 was even more remote, located on the N-
terminal b1–b2 hairpin. To further examine how the L10W
mutation might effect rhTRIM5a restriction of MLV we
determined the crystal structure of the CA-NtD of this variant at
2.0A ˚ resolution. The structure has been refined to a final Rwork/
Rfree of 17.4%/24.4% respectively and has excellent geometry
with only 3 residues in the additionally allowed region of the
Ramachandran plot (See Table 4 for details of crystal parameters,
phasing and data refinement statistics).
The structure of L10W was typical of a retroviral CA-NtD
consisting of an N-terminal b-hairpin and a core bundle of six a-
helices. A comparison with the native MLV CA-NtD structure
(Figure 6A) revealed an essentially identical backbone conforma-
tion. Pairwise comparisons of L10W with wt N-MLV CA-NtD gave
an RMSD of 0.6A ˚ across equivalent Ca atoms. However, minor
Table 3. Restriction sensitivity of L10 mutants and V116D to
primate TRIM5as.
Restriction
Origin of TRIM5 wt (10L) L10W L10H L10K V116D
Human ++ ++ ++ ++ ++
Gorilla ++ ++ ++ ++ ++
Orang-utan ++ ++ ++ ++ 2
Rhesus macaque ++ 222 2
Sooty mangabey ++ 222 ++
African green monkey ++ ++ ++ ++ ++
Cotton-top tamarin ++ + ++ ++ nd
Silvery marmoset 22 2 2 2
Squirrel monkey 22 2 2 nd
Brown capuchin ++ 222 ++
For the complete profile of titration curves, see Supplemental Data (Figure S3).
Representative results were shown from at least three independent
experiments.
++; restricted more than 10-fold compared to wild type, -; restricted less than
two-fold compared to wild type, and: +; partially restricted in between above
two criteria.
Chimeric TRIM5a of human RBCC domain fused with specified B30.2 domain nd,
not done.
doi:10.1371/journal.ppat.1002011.t003
Figure 5. Mapping regions of the B30.2 domain involved in MLV restriction. The left half of the figure shows schematic views of previously
described [16] chimeras between human (white shading) and rhesus macaque (gray shading) TRIM5a. The right side summarizes restriction data of
mutant viruses by these TRIM5a. For a full panel of titration curves, see Supplemental Data (Figure S4). Representative results are shown from one of
three independent experiments. MDTF cells were transduced with chimeric TRIM5a and cultivated for more than 4 weeks until cells reached the
steady expression level of TRIM5a. YFP expression was examined 4 weeks after transduction and more than 95% of total cells expressed YFP. TRIM5a-
expressing cells were infected with mutant viruses and the ratio of infected to non-infected cells was calculated in the YFP-positive cell fraction. +;
restricted more than 10-fold compare to wild type, 2; restricted less than two-fold compare to wild type, and 6; partially restricted.
doi:10.1371/journal.ppat.1002011.g005
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chains on the surface of the molecule. In particular, the L10W
mutation was clearly visible in the electron density (Supplementary
Figure S6) and was located on the inward facing side of strand b2
adjacent to the a5-a6 loop and the top of helix a6.
Examination of the wt N-MLV capsid surface in the proximity
of L10 (Figure 6B) reveals the presence of a shallow channel
between the b1–b2 hairpin and residues at the top of a6 and in the
a5–a6 loop. The channel walls are formed by side-chains of M4
and Q9 from the b1–b2 hairpin together with R112 and T107
from the a5–6 loop. At the bottom of the channel the aliphatic
L10 side-chain forms the base. However, in the L10W structure
(Figure 6C) the much bulkier tryptophan side-chain protrudes into
the channel along with R112 guanidinium moiety. Together they
adopt a near planar arrangement reminiscent of a similar
interaction seen in the structure of PSIV capsid [39]. Significantly,
this side-chain configuration in L10W reduces the depth of the
(b1–b2)-a6 channel by some 2.3A ˚, effectively closing the cavity
completely. To test the importance of the W10 – R112 interaction
for restriction, the R112 amino acid was mutated to an alanine in
presence of both L10 and W10. Both viruses were susceptible to
restriction by rhTRIM5a (Supplementary Figure S7). The
observed structural change thus provided a simple potential
explanation for the rhTRIM5a escape phenotype suggesting that
in wt N-MLV the (b1–b2)-a6 channel constituted at least part of
the rhTRIM5a binding site and that by blocking this channel in
L10W the interaction with rhTRIM5a was abolished or
sufficiently diminished to allow the virus to evade restriction.
Discussion
To better understand the interaction between TRIM5a and its
viral target, we set out to isolate a panel of novel N-MLV escape
mutants. Noting that direct inoculation of cells expressing a given
restriction factor led, depending on the initial virus titre, either to
rapid break-through of the block in replication or the absence of
replication (Figure 1), we devised a procedure allowing replication
against a background of restriction. We reasoned that the infection
of a mixture of restricting and non-restricting cells would allow
both multiple rounds of unrestricted replication as well as selection
for viruses that were unrecognized by restriction factor. Experi-
ments of the kind shown in Figure 2 illustrate the utility of such an
approach and have resulted in the isolation of a number of MLV
mutants that escape restriction by rhTRIM5a, apparently by
escaping premature capsid disassembly (Figure 4). The lack of
variation in mutants obtained with Stock A compared with that
from Stocks B and C points to the possible accumulation of variant
viruses in multi-passaged virus stocks even in the absence of overt
selection or apparent sequence variation and emphasize the need
for using freshly recovered virus in such studies.
b-hairpin mutants extend the MLV CA-restriction factor
interface
The mutations identified by these passaging experiments
together with in vitro mutagenesis studies all lie on the outer
‘‘top’’ surface of MLV CA (Figure 7) and can be divided into two
groups. One group (Class-I) comprises N82D, E92K, A95D, and
H114D/R/N, mutations that are within the previously defined
Fv1 binding pocket in the loop region between helices 4 and 6 of
CA [27,30]. These mutations result in escape from rhesus
TRIM5a mutations at these positions can affect susceptibility to
Fv1. The other escape mutants, L4S, G8D, L10W, L10K, L10H
and V116D are the founder members of a new group (Class-II)
located on the opposing side of the central a6 helix and in the b1–
b2 N-terminal b-hairpin. Residue 110 (R in N-MLV and E in B-
MLV) is located on the top of a6 and is often referred to as the
major specificity determinant of restriction as it was the first
residue shown to determine susceptibility to Fv1 or TRIM5a,
[8,19,31]. Our data now add further weight to the significance of
residue 110 revealing that it is located at the centre of an extended
restriction factor binding-site. This site encompasses the entire CA
top surface from N82 across the region containing Class-I mutants
to residues 8 and 10 in the b-hairpin. The G8D and mutations at
L10 are of particular interest as they are located in a region of CA,
the N-terminal b1–b2 hairpin, where mutations affecting the
interaction of N-MLV with TRIM5a or Fv1 have never before
been reported. The structure and properties of the L10W mutant
(Figure 6) and the effect of the R112A change (Supplementary
Figure S7) strongly suggest that the (b1–b2)-a6 channel present on
CA forms part of the rhTRIM5a binding site. The observation
that G8D and V116D cause susceptibility to Fv1
n further suggests
that the previous defined Fv1 binding pocket must be extended to
include this region.
It is noteworthy that residues 10 and 82 are 29 A ˚ (Ca-Ca) apart
on either side of the exposed surface of CA monomers making up
the core [32]. Moreover restriction sensitivity is affected by a
Table 4. Statistics of data collection, phasing and refinement.
Ncap-L10W
Data collection Home-Source
Space group C2
Cell dimensions a, b, c (A ˚), a, b, c (u) 71.9, 33.6, 59.3, 90, 111.9, 90
Wavelength (A ˚) 1.5418
Unique reflections 9015
Resolution range (A ˚) 25-2.0 (2.07-2.0)
Rsym (%) 4.4 (18.5)
I/s(I) 25.1 (6.29)
Completeness (%) 99.6 (97.0)
Redundancy 3.4 (2.9)
Phasing (MR Phaser)
Z-score 12.3
LLG 590
Refinement
Resolution (A ˚) 25-2.0 (2.29-2.0)
Rwork/Rfree (%) 17.4/24.4 (18.0/26.6)
No atoms (residues)
Protein 1088 (135)
Water 99
Glycerol 6 (1)
B-factors (A ˚2)
Wilson 30.3
Protein 35.8
Glycerol 47.7
Water 41.8
Overall 36.3
R.M.S. deviations
Bond lengths (A ˚) 0.009
Bond angles (u) 0.977
doi:10.1371/journal.ppat.1002011.t004
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distributed between these two positions, covering much of the
viral core that is exposed to cellular factors after entry into the
cytoplasm of newly infected cells (Figure 7). Many of these
residues posses poorly ordered side chains so their contribution to
arestriction factor binding seems most likely through side chain
charge-charge or hydrophobic interactions at the molecular
interface. Indeed many of the escape mutations we have isolated
involve introduction or loss of charged amino-acids. Further, in
cases of mutations affecting tropism for which we have detailed
structural information, R110E [27] and L10W (this paper) there
is no evidence for major change in the overall conformation of
CA, indicating that mutations in the N terminal b-hairpin loop
are not affecting the structure of other regions of CA for example
the a4–a6 region. Taken together, these observations are
consistent with the involvement of much, if not all, of the surface
of N-MLV CA in recognition and binding by rhesus TRIM5a.
Certainly the surfaces of the two proteins appear to lie in
sufficiently close proximity that the introduction of charged
residues in a variety of different positions prevents binding. An
extensive recognition surface fits well with distance measurements
of the B30.2 domain from TRIMs closely related to TRIM5
[40,41] that reveal that the specificity determiningV1 and V3
regions are separated by about 30 A ˚, a number very similar to
that between the two sides of CA residues (see above). However,
attempts to identify regions of TRIM5a that bind specific CA
residues using TRIM5a chimeras such as those illustrated in
Figure 5 have not met with great success; rather it appears that
well separated TRIM5a regions act in combinatorial fashion to
determine restriction specificity.
Comparison of the restriction factor binding sites on
different retroviruses
TRIM5a is capable of recognizing at least four genera of
retroviruses despite extensive differences in primary sequences of
CA [23,24,25]. However CA’s show extensive structural conser-
vation particularly in the core fold of helices 1–4 [42]. It thus
appears likely that it is some shared feature of overall structure that
represents the target for TRIM5a rather than direct sequence
specific recognition alone. Loop exchange studies involving
different lentiviruses suggest that the primary target for the
restriction factor lies in the cyclophilin A binding loop, in a region
analogous to the originally defined Fv1 binding site of MLV
[33,34]. The importance of this region is emphasized by the recent
isolation of an HIV-1 escape mutant from rhTRIM5a, V86M, by
methods similar to those used here [43] and the roles of HIV-2
P120 and G116 in resistance to cynomolgus macaque TRIM5a
[35,44]. HIV-1 V86 and MLV N82 both lie just C-terminal to
helix 4 while HIV-1 G116 and HIV-2 P120 lie close to position
110 of MLV. Further, domain swap experiments also suggest a
role for the b-hairpin region of SIV CA protein in the evasion from
rhTRIM5a-mediated restriction [36].
Based on these results and our success of producing and
mapping b-hairpin escape mutants of N-MLV that could evade
restriction by rhTRIM5a, it seemed logical to extend these studies
and test for commonality of binding by examining the restriction
phenotypes of b-hairpin mutants in HIV-1. Moreover, a
comparison of the CA-NtDs revealed that, although wider, the
b1-hairpin-a6 cleft is also present in HIV-1 (Supplementary Figure
S8). Therefore, it might be expected that the introduction of bulky
or charged side chains into this channel would alter HIV
susceptibility to TRIM5a in the same way as in N-MLV. To
this end, the studies presented in supplementary Figure S5 were
undertaken. However they showed that viable single amino acid
mutations in the HIV-1 b-hairpin had no effect on restriction by
rhTRIM5a. These data suggest that the b-hairpin-a6 cleft is not a
shared target for all viruses, implying that an as yet unidentified
binding region near the b-hairpin remains to be discovered. In any
event, it seems most likely that lentiviruses have an extended
TRIM5a binding site in analogous to that seen in MLV.
Figure 6. Structure of MLV CA-NtD (L10W). A) Structural superimposition a monomer of the CA-NtD from N-MLV (grey) and that of N-
MLV(L10W) (blue), side (upper) and top (lower) views are shown. Structures are displayed in cartoon representation, secondary structure elements are
labeled. B) Groove between b1–2 and a5–a6 in wt N-MLV. L10 in the base of the groove is shown in red. R112, T107, and Q9 lining the grove are
shown as sticks. A transparent molecular surface is shown over the molecule same orientation as A. C) W10 and R112 block the groove in the
structure of N-MLV L10W. The position of V116 on a6 is also shown.
doi:10.1371/journal.ppat.1002011.g006
Figure 7. Location of MLV restriction determinants. Determi-
nants of MLV restriction, side (lower) and top (upper) views of the N-
MLV CA-NtD structure are displayed. The protein backbone is shown in
cartoon representation together with the semi-transparent molecular
surface. Residues involved in restriction factor specificity are shown as
sticks. Determinants of N-B tropism are shown in yellow. Leu 10 that
when substituted by Trp, Lys or His confers resistance to rhTRIM5a is
shown in red. V116 that when substituted by Asp confers resistance to
rhTRIM5a and gives rise to Fv1n sensitivity is shown in blue.
doi:10.1371/journal.ppat.1002011.g007
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in the detail
The results of the initial passaging studies (Figure 1) together
with phenotypic analysis of our escape mutants (Figure 5) suggest
that there are significant differences in the recognition of N-MLV
by rhesus and human TRIM5a. From the outset, restriction of N-
MLV by huTRIM5a was much more potent to the extent that we
have been unable to overcome N-MLV restriction by the hu-
TRIM5a. Moreover, it is also refractory to all but one of the
changes isolated that allow escape from the rh-TRIM5a (Table 1).
The one exception, E92K, was resistant to all restriction factors
tested but showed a significant reduction in titre. These
observations suggested that the interaction of huTRIM5a with
N-MLV was either stronger and can elicit a more powerful host
cell response or that the CA-TRIM5a interface is different and
does not include the residues in the b-hairpin-a6 channel. These
observations are somewhat perplexing given the degree of
similarity of the TRIM5a B30.2 domains. However, it is notable
that L10 and V116D mutations have differential effects on
restriction by TRIM5as derived from other species. For example
V116D shows no restriction by orang-utan TRIM5a but is
restricted by sooty mangeby whereas L10W shows the converse
sensitivity (Table 1). Further, of the fourteen TRIM5as we have
previously examined only two, pigtailed macaque and sooty
mangabey, show identical restriction profiles against a panel of ten
different viruses [23,24,25].
Taken together, these variable determinants of restriction imply
that TRIM5a recognizes its targets in a manner significantly
differentfrommanyprotein-proteininteractionsthatinvolvea small
number of highly conserved residues, exemplified by the interaction
betweens HIV-1 CA and the cellular protein cyclophilin A [45].
Rather the interactions are predominately weak and spread over a
large surface.Avidity could then be provided by multivalent binding
to the regularly spaced CA molecules assembled on the viral core
[26,27,28]. This notion is further supported by recent structural
data suggesting that formation of a complementary TRIM5a lattice
is actually a requirement for a productive interaction of the
restriction factor with capsid aassemblies (Ganser-Pornillos et al,
2011). With the idea of lattice complementarity in mind it is also
interesting to note that although differences in conformationaround
the top of Helix-6 between wt and L10W are only very small
(,1.2A ˚) this region is centrally located in the extended restriction
factor binding-site. It is plausible that such small changes whilst not
affecting hexamer or CA lattice formation when propagated
throughout an entire capsid lattice could profoundly affect any
lattice complementarity, altering restriction factor susceptibility and
resulting in viral escape from some TRIM5as. Whatever the case,
retroviral pathogens comprise a wide range of sequence divergent
but structurally related assembled repeated capsid moieties [42].
Perhaps weak interactions spread over a large binding surface are
implicit in the design of a defence mechanism intended to recognize
these diverse targets.
Materials and Methods
Cells
Tail fibroblast cells from Mus dunni (MDTF), MDTF cells that
stably express restriction factors, and human 293T cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum and antibiotics. MDTF
cells expressing human and rhesus macaque TRIM5a (MDHu
and MDRh) were established by an end-point dilution method.
Stable, unselected expression of TRIM5a was observed in
transduced cells for at least one month after cloning.
DNA
The cloning of human TRIM5a from TE671 and a chimeric
human/rhesus macaque TRIM5a (human RBCC domain fused
with rhesus macaque B30.2 domain) have been described
previously [8,24]. This chimeric human/rhesus macaque
TRIM5a was used throughout this study to generate and select
escape mutants of N-MLV, thereby allowing a direct comparison
of interactions with the human and rhesus macaque B30.2
domains, avoiding confounding effects of the coiled coil region
[16,46,47], and will be referred to as rhesus TRIM5a. Generation
of transduction vectors expressing TRIM5a and Fv1 using the
Gateway system was also described previously [24,48]. Single
nucleotide mutations were introduced into the capsid genes of
Gag-Pol vector plasmids (pCIG3N and pCIG3B) and N-MLV
provirus plasmid (pWN41 [17]) by the QuickChange mutagenesis
PCR protocol. Random mutations were introduced at position 10
on MLV capsid by the QuickChange mutagenesis PCR using the
following primer pair: forward 59- ggggggtaatggtcagNN(G/
T)cagtactggccgttttc -39 and reverse 59- gaaaacggccagtactg(C/
A)NNctgaccattacccccc -39, where N indicates any nucleotide and
G/T and C/A indicate G or T and C or A, respectively. The
sequences of the other primers used to prepare mutants are
available upon request. All introduced mutations were verified by
DNA sequencing.
Viruses
Single-cycle replication viruses were produced by transfection of
VSV-G envelope (pcz VSV-G), retroviral gag-pol (pCIG3N and
pCIG3B for N- and B-tropic viruses, respectively) and viral
genomic plasmids (pczCFG2fEGFPf) into 293T cells by a
conventional calcium phosphate method as described previously
[48] or using Turbofect (Fermentas). Sixteen hours after
transfection, cells were treated with 10 mM sodium butyrate for
6 hours, followed by replacement of the culture supernatant with
fresh growth medium. Virus-containing supernatant was harvested
48 hours after transfection, filtered through a 0.45 mm pore filter
disk and stored at 280uC until usage. Three stocks of replication
competent N-MLV were used. One (Stock A) was prepared from
the culture supernatant of MDTF cells transfected with N-MLV
provirus (pWN41) followed by multiple (.20x) passage of the
transfected cells. The second (Stock B) was generated by
transfection of 293T cells with pWN41, transfer of the filtered
supernatant to MDTF cells followed by three cell passages. The
third (Stock C) was unpassaged supernatant of 293T cells
transfected with pWN41. For transfection, pWN41 DNA was
digested with Hind III to separate the permuted provirus from the
vector, and purified viral DNA fragments were self-ligated with T4
DNA ligase at 16uC overnight. After purification, the ligated DNA
was introduced into MDTF/293T cells using a commercial
transfection reagent according to the manufacturer’s instructions
(TurboFect, Fermentas). Transfected cells were re-fed with fresh
medium after 16 hours; culture supernatants were harvested after
48 hours.
Virus production in newly transfected/infected cells was
monitored by protein blotting of pelleted culture supernatants
with monoclonal antibodies specific to p12 and CA viral antigens
(prepared from the culture supernatant of hybridomas 548 and
R187 [ATCC]) or with a RT assay kit used according to the
manufacturer’s instructions (C-type RT assay kit, Cavidi Tech,
Sweden).
Mutant virus selection. Target cells (MDTFs or rhTRIM5a
expressing MDTFs or specified mixtures of the two cell types) were
seeded on a 6-well plate at 2610
5 cells per well one day before
virus inoculation. Replication competent N-MLV was added to
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by washing cells three times with the growth medium 16 hours
after infection. The input virus was allowed to grow in the culture
by passing infected cells and virus spread was assessed by
fluorescent staining. Once the majority of restriction factor
positive cells were infected with N-MLV, the culture supernatant
was harvested, filtered, and then stored at 280uC until usage. The
filtered supernatant was diluted 1:10 with growth medium and
inoculated onto fresh, restriction factor-expressing cells. This virus
passage cycle was repeated several times until the virus spread
rapidly in restriction factor positive cells.
FACS
Virus spread in infected cells was monitored by detection of an
intracellular virus antigen, p12. Infected cells were harvested by
trypsinization and washed with PBS, followed by fixation with
1.25% ice-cold paraformaldehyde in PBS. All of the following
procedures were performed on ice. Fixed cells were washed once
with permeabilization buffer (0.5 mg/ml digitonin and 1% bovine
serum albumin [BSA] in PBS), followed by incubation with anti-
p12 monoclonal antibody diluted in permeabilisation buffer. After
washing three times with wash buffer (5% Tween-20 and 1% BSA
in PBS), cells were then stained with anti-mouse IgG conjugated
with AlexaFluor 594 (Invitrogen) diluted in permeabilisation
buffer. After washing three times, cells were re-suspended in
1.25% paraformaldehyde in PBS and analysed by FACSCalibur
within four hours.
Single-cycle replication experiments were performed as previ-
ously described [24,48] using a delivery vector encoding restriction
factor and eYFP and a tester virus encoding eGFP. Two colour
FACS was carried out with a BD LSR II machine.
Sequencing of the capsid gene
Virus containing culture supernatant was harvested and filtered
through a 0.45 mm-pore filter disk. The filtered supernatant was
stored at 280uC until usage. The supernatant was treated with
MgCl2 and RNase-free DNase I at 37uC for 2 hours to degrade
contaminating DNA. DNase I-treated supernatant was subjected
to viral RNA extraction using a commercial kit (Viral RNA mini
kit, QIAGEN). A single strand cDNA spanning the capsid region
was synthesized from viral RNA as a template with a primer
designed in the protease gene (59-gggttatcctgggttcaggggggggctcct-
gaccctg-39) using a commercial kit (Transcriptor High Fidelity
cDNA synthesis kit, Roche). The cDNA synthesized was used as a
template to amplify viral capsid gene with a primer pair designed
in viral matrix (59-gtctcgcctgcggggcaaaagag-39) and protease (the
same as above) genes using PfuUltra high fidelity DNA polymerase
(Stratagene). The PCR product was gel purified, and nucleotide
sequence was determined by direct sequencing.
Fate-of-capsid assay
The fate-of-capsid assay was performed as previously described
[38] with minor modifications. MDTF cells expressing TRIM5a
(5610
6 cells in a 80 cm
2 tissue culture flask) were pre-plated one
day before assay. Cells were inoculated with freshly prepared,
chilled virus (14 ml per flask with 5 ug/ml polybrene) from the
filtered culture supernatant of transiently transfected 293T cells.
After incubation on ice for 30 minutes, cells were incubated at
37uC for 4 hours. Cells were then washed three times with ice-cold
PBS and treated with 1 ml of 7 mg/ml pronase at room
temperature for 5 minutes. Cells were re-suspended in ice-cold
growth medium and washed three times with ice-cold PBS. Cells
were re-suspended in 2.5 ml of hypotonic lysis buffer [10 mM
Tris-HCl (pH 8.0), 10 mM KCl, 1 mM EDTA and protease
inhibitor cocktail] and incubated on ice for 15 minutes. Swollen
cells were lysed in a 7 ml-Dounce homogenizer with a ‘tight’ pestle
(15 gentle strokes) and cell lysates cleared by centrifugation at 4uC
and 1,850 xg for 3 minutes. Cleared cell extracts (2 ml) were
layered over 50% sucrose cushions prepared in PBS and
centrifuged at 4uC and 125,000 xg for 2 hours in a Beckman
SW41 rotor and 100 ml of the cell extract was collected as a ‘input’
fraction. After the centrifugation, 100 ml of the topmost portion of
the supernatant was collected as a ‘soluble’ fraction. The pellet was
re-suspended in 100 ml1 6SDS sample loading buffer (‘pellet’
fraction). Samples were separated on acrylamide gels and blotted
for CA as described above.
Protein crystallisation and structure determination
The CA N-terminal domain of N-MLV(L10W) was crystallised
by sitting-drop vapour diffusion using a reservoir solution
containing 24% PEG-8000, 0.1M phosphate citrate, pH 5.0
mixed with an equal volume of protein solution (14 mg/ml).
Prior to data collection, crystals were transferred into a
cryoprotectant of reservoir solution containing 20% glycerol and
flash frozen in liquid nitrogen. X-ray diffraction data were
collected at 100u K on a Rigaku Micromax-007HF with a
Raxis-IV detector to a resolution of 2.0A ˚ and processed using the
HKL program package [49]. Crystals belonged to the space group
C2 with the cell dimensions a=71.9A ˚, b=33.6A ˚, c=59.3A ˚,
b=111.9u.
The structure of N-MLV(L10W) was determined by molecular
replacement using a monomer of N-MLV CA-NtD (1U7K) as a
search model in PHASER [50]. A single molecule was present in
the asymmetric unit (Z-score 12.3, LLG 590). The model was
rebuilt using Arp/Warp (Morris et al., 2003) followed by iterative
rounds of refinement and model building in PHENIX [51] and
COOT [52]. Nine TLS groups were included in final round of
refinement as determined by TLSMD [53]. The structure was
refined to a final Rwork/Rfree of 17.4%/24.4% respectively.
Coordinates
The coordinates and structure factors of N-MLV(L10W) have
been deposited in the Protein Data Bank under accession number
2y4z.
Supporting Information
Figure S1 Restriction of N-MLV vectors carrying various escape
mutations. eGFP-encoding vector virus (A, H114D; B, H114N; C,
H114R; D, L4S; E, A95D; F, L4S/A95D; G, L4S/S202G; H,
A95D, S202G; I, S202G; J, G8D; K, N82D; L, 92K) were titrated
on MDTF cells stably expressing restriction factors (TRIM5-
negative, open diamond; human TRIM5a, filled square; rhesus
TRIM5a, filled red triangle; Fv1
b, filled circle; Fv1
n, asterisk).
Experiments were performed in triplicate; mean values from one
representative experiment from three are plotted.
(TIF)
Figure S2 Restriction by rhesus macaque TRIM5a of N-MLV
carrying different amino acids at CA position 10. A variety of
amino acids were introduced at position 10 of CA by random
mutagenesis. Unique isolates were tested for growth in the
presence (solid line and filled squares) or absence (dotted line
and open diamonds) of rhesus macaque TRIM5a. One represen-
tative result from three independent experiments is shown. These
data are summarized in Table 2.
(TIF)
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in the presence of various primate TRIM5a. Chimeric TRIM5a
constructs expressing the human RBCC domain fused with
different primate B30.2 domains [24] were used to test restriction
of wild type and L10W, L10H, L10K and V116D escape mutant
virus. Titration curves in the presence of ape, old world monkey
and new world money TRIM5a are shown in green (left column),
red (middle column) and blue (right column), respectively. One
representative result is shown from three independent experi-
ments. These data are summarized in Table 3.
(TIF)
Figure S4 Titration curves of N-MLV escape mutants in the
presence of chimeric TRIM5a. Titration curves in the presence of
human-rhesus TRIM5a chimeras are shown in the left column
and those in the presence of rhesus-human TRIM5a chimera are
shown in the right column. One representative result from three
independent experiments is shown. These data are summarized in
Figure 5.
(TIF)
Figure S5 Titration curves of HIV-1 with lysine-substitutions
within the CA b-hairpin loop. Lysine substitutions were intro-
duced at amino acid positions 5 through 12 of HIV-1 CA as well
as random amino acid mutations at position 10. These were tested
for growth in the presence (solid line and filled squares) or absence
(dotted line and open diamonds) of rhTRIM5a. Data for the I6K,
G8K and H12K mutants showed much reduced infectivity and
are not shown. One representative result from two independent
experiments is shown.
(TIF)
Figure S6 Stereo 2Fo-Fc electron density. Maps contoured at
1.0s around the region of N-MLV containing either L10 (1U7K)
in panel A or W10 (2Y4Z) in panel B are shown. The protein
main-chain is shown in cartoon representation, residue side chains
are shown in stick representation, L10 and W10 are highlighted in
red.
(TIF)
Figure S7 Mutation R112A abolishes relief of TRIM 5a
restriction by L10W. Single cycle experiments to examine the
effect of the R112A mutation on restriction of wt and L10W N-
MLV by TRIM5a. Infection was tested in the presence (filled
squares) or absence (open diamonds) of rhTRIM5a. Panel A, N-
MLV carrying the L10W mutation; Panel B. N-MLV with
R112A; Panel C, N-MLV with L10W and R112A. One
representative result from three independent experiments is
shown.
(TIF)
Figure S8 The b1-b2-a6 cleft in HIV-1 CA-NtD. Side (lower)
and top (upper) views of the HIV-1 CA-NtD structure are
displayed (PDB ID 1M9C). The protein backbone is shown in
cartoon representation together with the semi-transparent molec-
ular surface. Residues in the amino-terminal b-hairpin that were
mutated in order to look for escape from rhesus TRIM5a
restriction are shown in stick representation. The cleft between b1-
b2 and helix 59 at the top of a6 is much wider in HIV than in
MLV; cf. Figure 6.
(TIF)
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